Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.
The search for biologic markers that can assess the natural history and perhaps predict the course of individual's disease including response to treatments over time has become an important focus of inflammatory bowel disease research. The knowledge of an individual's prognosis can help physicians and patients make important management decisions and aid communication on risk and benefits of disease and treatment.
Dubinsky
Marla Cindy
MC
Pediatric IBD Center, Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. marla.dubinsky@cshs.org
D015415:Biomarkers / Q000378:metabolism*; D002097:C-Reactive Protein / Q000378:metabolism; D018450:Disease Progression; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D039841:Leukocyte L1 Antigen Complex / Q000378:metabolism
D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex; D002097:C-Reactive Protein